earnings call
Lician Pro · $19.99/mo or $149/yr · AAPL vs MSFT
Inhibikase Therapeutics Inc (IKT) SEC filings
Inhibikase Therapeutics Inc (IKT) SEC filings — 10-K, 10-Q, 8-K, and Form 4 as cached from EDGAR. When an exhibit lands, this page shows the headline, the numbers, and why it matters.
Those exhibit numbers sit next to the income-statement cache: Latest reported IKT revenue for 2026-06-30 was $0. Net income was -$19.6M. IKT currently screens at market cap $215.2M. The IKT filings page is the source view; the stock page is the research view.
EDGAR remains the official archive. Lician caches 8-K exhibits so you can read what Inhibikase Therapeutics Inc said without waiting on a live EDGAR scrape. Item 2.02 is the earnings exhibit — this page prefers EX-99.1 revenue, growth, EPS, and guidance over a form-type label. Form 4 insider prints stay on the same ticker timeline.
Earnings & events
All eventsearnings call
Event insights for IKT — what management said, what changed, and why it matters.
Recent filings
IKT SEC filings FAQ
What is the latest IKT SEC filing?
The latest cached Inhibikase Therapeutics Inc (IKT) filing on this page is 8-K · Sep 8, 2026. Filings: https://lician.com/sec/ikt
What is the latest IKT filing accession number?
The latest cached Inhibikase Therapeutics Inc (IKT) accession number on this page is 0001193125-26-385293. Filing: https://lician.com/sec/ikt/0001193125-26-385293
Which item codes are on the latest IKT filing?
Cached item codes on the latest Inhibikase Therapeutics Inc (IKT) 8-K are 7.01, 9.01.
How many IKT SEC filings are listed on this page?
This page lists 4 cached Inhibikase Therapeutics Inc (IKT) SEC filings. Filings: https://lician.com/sec/ikt
What events are listed on the IKT SEC page?
Cached event headlines on this Inhibikase Therapeutics Inc (IKT) SEC page: "IKT earnings". Events: https://lician.com/sec/ikt
What is IKT's latest net income?
Latest cached Inhibikase Therapeutics Inc (IKT) net income was -$19.6M. Statements: https://lician.com/financials/ikt